Cirius’ Mixed Phase IIb Results In NASH Don’t Quell Its Enthusiasm For Phase III

 
• By Joseph Haas
Glycogen in liver and muscle. Insulin sensitive and Insulin resistant. - Vector
Cirius believes an insulin-sensitizer approach will succeed in NASH

More from Clinical Trials

More from R&D